NTRA - Natera Inc | StockAlert.pro

Stock Details

Natera Inc (NTRA), a prominent company in the life sciences sector within the services-medical laboratories industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $168.51. Over the past 52 weeks, it has ranged between $117.27 and $183.00. This places the current price at 92.1% of its 52-week high and 43.7% above its 52-week low. Recent trading volume was recorded at 853,083. The 14-day Relative Strength Index (RSI) stands at 43.06, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $160.71 by 4.85%. Similarly, it is above its 200-day moving average of $153.49 by 9.79%. The MACD histogram is -1.13, indicating bearish momentum (MACD Line: -0.54, Signal Line: 0.59).

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

PEG Ratio

0.00

Potentially undervalued

Price to Book

18.53

EV/EBITDA

-26.80

EPS (TTM)

-$1.92

Price to Sales

11.76

Beta

1.76

More volatile than market

How is NTRA valued relative to its earnings and growth?

Valuation data is not available for this stock.

What is NTRA's risk profile compared to the market?

With a beta of 1.76, Natera Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 18% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 18.53 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-12.90%

Operating Margin

-20.20%

Return on Equity

-24.30%

Return on Assets

-11.20%

Revenue Growth (YoY)

32.20%

Earnings Growth (YoY)

0.00%

How profitable and efficient is NTRA's business model?

Natera Inc achieves a profit margin of -12.90%, meaning it retains $-12.90 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -20.20% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -24.30% and ROA at -11.20%, the company achieves moderate returns on invested capital.

What are NTRA's recent growth trends?

Natera Inc's revenue grew by 32.20% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends.0 These growth metrics should be evaluated against SERVICES-MEDICAL LABORATORIES industry averages for proper context.

Company Size & Market

Shares Outstanding

137.25M

Book Value/Share

$9.11

Asset Type

Common Stock

What is NTRA's market capitalization and position?

Natera Inc has a market capitalization of $23.09B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 137.25M shares outstanding, the company's ownership is relatively concentrated. As a participant in the SERVICES-MEDICAL LABORATORIES industry, it competes with other firms in this sector.

How does NTRA's price compare to its book value?

Natera Inc's book value per share is $9.11, while the current stock price is $168.51, resulting in a price-to-book (P/B) ratio of 18.50. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$197.80

17.38% upside potential

Analyst Recommendations

Strong Buy

Buy

Hold

Sell

Strong Sell

How reliable are analyst predictions for NTRA?

20 analysts cover NTRA with 95% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $197.80 implies 17.4% upside, but targets are often adjusted to follow price moves rather than predict them.

What is the Wall Street consensus on NTRA?

Current analyst recommendations:6 Strong Buy, 13 Buy, 001 Strong Sell. The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Sep 1, 2025, 05:48 AM

Technical Indicators

RSI (14-day)

43.06

Neutral

50-Day Moving Average

$160.71

4.85% above MA-50

200-Day Moving Average

$153.49

9.79% above MA-200

MACD Line

-0.54

MACD Signal

0.59

MACD Histogram

-1.13

Bearish

What does NTRA's RSI value tell investors?

The RSI (Relative Strength Index) for NTRA is currently 43.06, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this shows mixed signals requiring careful analysis.

How should traders interpret NTRA's MACD and moving average crossovers?

MACD analysis shows the MACD line at -0.54 below the signal line at 0.59, with histogram at -1.13. This bearish crossover indicates downward pressure. The wide histogram confirms strong momentum. The 50-day MA ($160.71) is above the 200-day MA ($153.49), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Jul 15, 2025, 12:42 AM

Natera Inc (NTRA) Stock